by Pharmaceutical glass tubing refers to medical-grade borosilicate glass used in the manufacturing of injectable drug delivery systems such as cartridges,ampoules and pre-filled syringes. Glass is highly compatible with most pharmaceutical formulations and can withstand high pressures and temperatures during manufacture, steam sterilization and transport. Pharmaceutical glass tubing ensures product stability and sterility during storage and prevents interaction between drug and container material. The increasing demand for pre-filled syringes across the globe is driving the growth of the pharmaceutical glass tubing market. Pre-filled syringes offer advantages such as accurate dosing, reduced risk of contamination and needle stick injuries. They provide convenience to patients and healthcare providers.
The global pharmaceutical glass tubing Market is estimated to be valued at US$ 8.3 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by CoherentMI.
Market Dynamics:
Growing need for pre-filled syringes: As mentioned earlier, the growing demand for pre-filled syringes across the globe is fuelling the pharmaceutical glass tubing market. Pre-filled syringes offer significant advantages over traditional vial-and-syringe systems.
Stringent regulatory norms: Pharmaceutical glass tubing manufacturers have to adhere to stringent quality standards and undergo thorough regulatory scrutiny. Regulations such as the U.S.P. type 1 glass help ensure product quality and safely. Compliance increases production costs but also boosts customer confidence.
Segment Analysis:
The global pharmaceutical glass tubing market is dominated by Type I Pharmaceutical Glass (borosilicate glass). It holds more than 60% share owing to its high resistance against chemicals, heat stability and low reactivity making it ideal for packaging injectable and ophthalmic drugs. Type I glass is less dense and more thermally stable than soda lime glass, hence offers better protection for drugs during transportation and storage without compromising on purity and stability of drug content.
Global Pharmaceutical Glass Tubing Market Segmentation:
- By Product Type
- Vials
- Ampoules
- Cartridges
- Syringes
- Bottles
- Others (Tubes, Rods, Stoppers etc.)
- By End User
- Pharmaceutical
- Biotechnology
- Diagnostics
- Chemical
- Others (Research, Forensics etc.)
- By Distribution Channel
- Direct Sales
- Distributors
- Online
- Others
- By Manufacturing Process
- Tubing
- Molding
- Extrusion
- Others
PEST Analysis:
Political: Stringent regulations around manufacturing, handling and packaging of pharmaceutical products ensure hygienic, safe and contamination-free glass tubing.
Economic: Rising healthcare spending in emerging nations drives demand. However, increasing pricing pressure on pharma companies can negatively impact glass tubing manufacturers.
Social: Growing elderly population and lifestyle diseases raise need for innovative drugs and diagnostics, benefitting glass tubing use.
Technological: Investments in developing high strength, thinner walled borosilicate glass tubing through improved glass formulation and processing methods helps reduce material consumption.
Key Takeaways:
The global Pharmaceutical Glass Tubing Market Size is expected to witness high growth over the forecast period of 2023 to 2030 supported by rising healthcare spending, increasing generics market and growth in biologics. The global pharmaceutical glass tubing Market is estimated to be valued at US$ 8.3 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030.
Regional Analysis: North America holds the largest share currently owing to presence of many pharma research companies and sterile manufacturing facilities. Asia Pacific is expected to witness the fastest growth over the coming years led by China, India and other Southeast Asian countries where GDP growth and healthcare infrastructure expansion are driving higher pharmaceutical consumption and production.
Key Players: Key players operating in the pharmaceutical glass tubing market include Schott AG, Nipro PharmaPackaging International, Corning Incorporated, Nippon Electric Glass, Cangzhou Four-Star Glass, LINUO Group, DWK Life Sciences, Puyang New Harmony Industrial Development among others. Schott AG leads the global market with wide product portfolio for tubing, vials, cartridges catering to diverse pharma dosage requirements.
*Note:
1.Source: CoherentMI, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
